Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases.
Strowski
Mathias Z
MZ
Medizinische Klinik m S Hepatologie, Gastroenterologie, & Interdisziplinäres Stoffwechsel-Centrum/Endokrinologie und Diabetes mellitus, Charité - Universitätsmedizin Berlin, 13353 Berlin, Germany. mathias.strowski@charite.de
Wiedenmann
Bertram
B
D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy*; D007249:Inflammation / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy; D007422:Intestines / Q000382:microbiology / Q000503:physiopathology*; D051379:Mice; D009765:Obesity / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy*; D010539:Permeability; D019936:Probiotics / Q000627:therapeutic use*